Application of da Vinci SP for Endometrial Cancer Surgical Staging
ConditionEndometrial Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorNational Cancer Institute, Naples
About this trial
Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma)
Performance status (ECOG) 0 - 1
Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy/pelvic ± para-aortic lymphadenectomy
Disqualifiers
Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma
Patients with anesthesiological contraindications to a minimally invasive approach
Synchronous tumor
Recurrence of endometrial carcinoma
Trial design
Treatments tested in this trial
- Robotic surgical staging
Treatment groups
564 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov